PDF(1122 KB)
布拉氏酵母菌联合光疗治疗新生儿高胆红素血症的疗效：前瞻性随机对照研究
唐炜, 卢红艳, 孙勤, 许为民
中国当代儿科杂志 ›› 2020, Vol. 22 ›› Issue (11) : 1149-1153.
PDF(1122 KB)
PDF(1122 KB)
布拉氏酵母菌联合光疗治疗新生儿高胆红素血症的疗效：前瞻性随机对照研究
Effectiveness of Saccharomyces boulardii combined with phototherapy in the treatment of hyperbilirubinemia in neonates: a prospective randomized controlled trial
目的 探讨布拉氏酵母菌联合光疗治疗新生儿高胆红素血症的疗效。方法 将2018年1~12月入院治疗的高胆红素血症新生儿随机分为观察组（n=61）和对照组（n=63）。观察组给予光疗+布拉氏酵母菌散，对照组给予光疗+安慰剂，比较两组的治疗效果。治疗72 h后收集患儿粪便样本，通过16s rRNA高通量测序方法分析比较两组新生儿肠道菌群特征。结果 观察组和对照组治疗前总胆红素水平差异无统计学意义（P > 0.05）。观察组治疗24、48、72 h后的总胆红素水平均显著低于对照组（P < 0.05）。观察组需要再次给予光疗的新生儿比例（12例，20%）显著低于对照组（47例，75%）（P < 0.05）。治疗72 h后观察组肠道内拟杆菌属丰度较对照组高（P < 0.05），大肠埃希菌属和葡萄球菌属丰度较对照组低（P < 0.05）。结论 光疗联合布拉氏酵母菌治疗对于降低高胆红素血症新生儿胆红素水平及预防黄疸退而复现有较好的疗效。布拉氏酵母菌可能通过调节患儿肠道菌群改善治疗疗效。
Objective To study the effectiveness of Saccharomyces boulardii combined with phototherapy in the treatment of hyperbilirubinemia in neonates. Methods The neonates with hyperbilirubinemia who were hospitalized from January to December 2018 were enrolled and randomly divided into an observation group (n=61) and a control group (n=63). The neonates in the observation group were treated with phototherapy combined with Saccharomyces boulardii, and those in the control group were treated with phototherapy combined with placebo. Treatment outcomes were compared between the two groups. Fecal samples were collected 72 hours after treatment and 16s rRNA high-throughput sequencing was used to compare the features of gut microbiota between the two groups. Results There was no significant difference in the total serum bilirubin level between the two groups before treatment (P > 0.05). At 24, 48, and 72 hours after treatment, the observation group had a significantly lower level of total serum bilirubin than the control group (P < 0.05). Compared with the control group, the observation group had a significantly lower proportion of neonates requiring phototherapy again[20% (12/61) vs 75% (47/63), P < 0.05]. Compared with the control group, the observation group had a significantly higher abundance of Bacteroides (P < 0.05) and a significantly lower abundance of Escherichia coli and Staphylococcus in the intestine at 72 hours after treatment (P < 0.05). Conclusions In neonates with hyperbilirubinemia, phototherapy combined with Saccharomyces boulardii can effectively reduce bilirubin level and prevent the recurrence of jaundice. Saccharomyces boulardii can favour the treatment outcome by regulating the gut microbiota of neonates.
Hyperbilirubinemia / Saccharomyces boulardii / Gut microbiota / Neonate
[1] Bhutani VK, Vilms RJ, Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia[J]. J Perinatol, 2010, 30(Suppl 1):S6-S15.
[2] Najati N, Gharebaghi MM, Mortazavi F. Underlying etiologies of prolonged icterus in neonates[J]. Pak J Biol Sci, 2010, 13(14):711-714.
[3] Henny-Harry C, Trotman H. Epidemiology of neonatal jaundice at the University Hospital of the West Indies[J]. West Indian Med J, 2012, 61(1):37-42.
[4] Dollberg S, Atherton HD, Hoath SB. Effect of different phototherapy lights on incubator characteristics and dynamics under three modes of servocontrol[J]. Am J Perinatol, 1995, 12(1):55-60.
[5] Maayan-Metzger A, Yosipovitch G, Hadad E, et al. Transepidermal water loss and skin hydration in preterm infants during phototherapy[J]. Am J Perinatol, 2001, 18(7):393-396.
[6] Kopelman AE, Brown RS, Odell GB. The "bronze" baby syndrome:a complication of phototherapy[J]. J Pediatr, 1972, 81(3):466-472.
[7] Rubaltelli FF, Jori G, Reddi E. Bronze baby syndrome:a new porphyrin-related disorder[J]. Pediatr Res, 1983, 17(5):327-330.
[8] Aspberg S, Dahlquist G, Kahan T, et al. Is neonatal phototherapy associated with an increased risk for hospitalized childhood bronchial asthma?[J]. Pediatr Allergy Immunol, 2007, 18(4):313-319.
[9] Martin CR, Cloherty JP. Neonatal hyperbilirubinemia[M]//Cloherty JP, Eichenwald EC, Stark AR. Manual of Neonatal Care. 6th ed. Philadelphia PA:Lippincott Williams and Wilkins, 2008:201.
[10] Singh M. Jaundice:Care of the Newborn[M]. 7th ed. New Delhi:Sagar Publication, 2010:254-274.
[11] Demirel G, Celik IH, Erdeve O, et al. Impact of probiotics on the course of indirect hyperbilirubinemia and phototherapy duration in very low birth weight infants[J]. J Matern Fetal Neonatal Med, 2013, 26(2):215-218.
[12] 中华医学会儿科学分会新生儿学组, 《中华儿科杂志》编辑委员会. 新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志, 2014, 52(10):745-748.
[13] Liu W, Liu H, Wang T, et al. Therapeutic effects of probiotics on neonatal jaundice[J]. Pak J Med Sci, 2015, 31(5):1172-1175.
[14] Serce O, Gursoy T, Ovali F, et al. Effects of Saccharomyces boulardii on neonatal hyperbilirubinemia:a randomized controlled trial[J]. Am J Perinatol, 2015, 30(2):137-142.
[15] Jiménez E, Marín ML, Martín R, et al. Is meconium from healthy newborns actually sterile?[J]. Res Microbiol, 2008, 159(3):187-193.
[16] Palmer C, Bik EM, DiGiulio DB, et al. Development of the human infant intestinal microbiota[J]. PLoS Biol, 2007, 5(7):e177.
[17] Leser TD, Amenuvor JZ, Jensen TK, et al. Culture-independent analysis of gut bacteria:the pig gastrointestinal tract microbiota revisited[J]. Appl Environ Microbiol, 2002, 68(2):673-690.
[18] Dave M, Higgins PD, Middha S, et al. The human gut microbiome:current knowledge, challenges, and future directions[J]. Transl Res, 2012, 160:246-257.
[19] 陈昌辉, 吴青, 李茂军. 新生儿黄疸的诊治及其相关问题[J]. 实用儿科临床杂志, 2011, 26(14):1132-1136.
[20] Foster TJ, Geoghegan JA, Ganesh VK, et al. Adhesion, invasion and evasion:the many functions of the surface proteins of Staphylococcus aureus[J]. Nat Rev Microbiol, 2014, 12(1):49-62.
[21] Winstel V, Missiakas D, Schneewind O. Staphylococcus aureus targets the purine salvage pathway to kill phagocytes[J]. Proc Natl Acad Sci U S A, 2018, 115(26):6846-6851.
[22] Creech CB, Frenck RW, Sheldon EA, et al. Safety, tolerability and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults[J]. Open Forum Infect Di, 2015, 2(Suppl 1):746.
[23] Lee E, Kim BJ, Kang MJ, et al. Dynamics of gut microbiota according to the delivery mode in healthy Korean infants[J]. Allergy Asthma Immunol Res, 2016, 8(5):471-477.
[24] Rocha ER, Smith CJ. Ferritin-like family proteins in the anaerobe Bacteroides fragilis:when an oxygen storm is coming, take your iron to the shelter[J]. Biometals, 2013, 26(4):577-591.
[25] Wexler AG, Goodman AL. An insider's perspective:Bacteroides as a window into the microbiome[J]. Nat Microbiol, 2017, 2:17026.
[26] Wallace BD, Roberts AB, Pollet RM, et al. Structure and inhibition of microbiome β-glucuronidases essential to the alleviation of cancer drug toxicity[J]. Chem Biol, 2015, 22(9):1238-1249.
[27] Pollet RM, D'agostino EH, Walton WG, et al. An Atlas of β-glucuronidases in the human intestinal microbiome[J]. Structure, 2017, 25(7):967-977.e1-e5.
[28] Madan A, MacMahon JR, Stevenson DK. Neonatal hyperbilirubinemia[M]//Taeusch HV, Ballard RA, Gleason CA. Avery's Diseases of the Newborn. 8th ed. Philadelphia, PA:Elsevier Publication, 2005:1226-1256.
江苏省妇幼健康科研项目（F201648）；镇江市社会发展项目（SH2019055）；江苏省妇幼健康重点人才项目（FRC201735）。
